Misonix Inc
MSON
MSON was delisted on the 28th of October, 2021.
1 hedge funds and large institutions have $9K invested in Misonix Inc in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 69 closing their positions.
99% less funds holding
Funds holding: 69 → 1 (-68)
99% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 69
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $189M → $9K (-$189M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CT
Cambridge Trust
Cambridge,
Massachusetts
|
+$8.41K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SHI
SV Health Investors
Boston,
Massachusetts
|
-$42.9M |
| 2 |
RA
Royce & Associates
New York
|
-$21.3M |
| 3 |
BlackRock
New York
|
-$20.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$16M |
| 5 |
JIC
Juniper Investment Company
New York
|
-$11.8M |
MSON Hedge Fund Activity: Q4 2021 in Review
1 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Misonix Inc (MSON) for Q4 2021, worth a combined $9K — down 100% from $189M a quarter earlier.
Sellers outnumbered buyers: 69 funds closed out of MSON and 1 opened new positions — a net loss of 68 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Cambridge Trust, opening a new position worth an estimated $8.41K. The largest seller was SV Health Investors, exiting entirely with an estimated $42.9M sold.
- 1 institutional investor held Misonix Inc (MSON) as of Q4 2021, down from 69 in Q3 2021.
- Funds reported $9K of Misonix Inc stock for Q4 2021, down 100% quarter-over-quarter.
- 1 fund opened new Misonix Inc positions in Q4 2021 and 69 closed out, a net change of -68 holders.
- The largest Misonix Inc buyer in Q4 2021 was Cambridge Trust, an estimated $8.41K added.
- The largest Misonix Inc seller in Q4 2021 was SV Health Investors, an estimated $42.9M sold.
Based on aggregated 13F filings for Q4 2021.